When protozoa and bacteria team up to cause chronic diarrhoea in cats

The feline intestinal tract hosts a complex microbial community, and when protozoa and bacteria disrupt this balance together, persistent diarrhoea often follows. Australian veterinary teams, from inner-city clinics in Melbourne to mixed practices across the Top End, regularly encounter this overlap in both pampered indoor cats and working farm felines. The clinical picture is rarely one organism acting alone; it is usually a shifting partnership between eukaryotes and bacteria that determines chronicity.

Modern research frames feline chronic enteropathies as disorders of host-microbe dialogue, where pathogens such as Tritrichomonas foetus or Giardia rarely cause persistent disease without concurrent bacterial shifts. Canine findings on barrier dysfunction, including this overview of leaky gut in canine enteropathies, parallel many of the mucosal changes seen in affected cats. Recognising this overlap helps clinicians avoid chasing single organisms while missing the wider dysbiosis.

Diet shapes which microbial groups gain ground, and a growing body of evidence suggests that nutrient form, fibre, and moisture drive bacterial composition. Work on raw versus cooked feeding demonstrates this clearly, and the same principles translate to feline gastroenterology. Owners who free-feed dry kibble alongside fresh protein may inadvertently support very different microbial profiles than those feeding a uniform ration.

Protozoal suspects in Australian cats

Tritrichomonas foetus is the most frequently identified protozoan in chronic feline colitis across Australia, particularly in younger animals from catteries, shelters, and multi-cat households. Clinics in Sydney and Brisbane routinely diagnose it in pedigree breeds such as Bengal and Siberian, where shared litter trays accelerate transmission. The organism produces foul-smelling, mucus-rich, intermittent stools that come and go over months, often fooling owners into blaming diet alone.

Giardia duodenalis, particularly assemblages F and A, also drives persistent diarrhoea in cats. In regional Queensland and the Northern Territory, where cats access surface water and roam semi-wild, prevalence rises noticeably. Many infections remain subclinical until bacterial dysbiosis converts a quiet carrier into a symptomatic patient, especially in kittens under twelve months old.

Less commonly, Cystoisospora and Cryptosporidium felis are implicated in persistent cases, typically in immunocompromised or very young patients. Their clinical relevance often emerges after a protozoal infestation has already disrupted mucosal integrity, setting the stage for sustained inflammation driven by bacterial partners.

Bacterial shifts in feline dysbiosis

Bacterial communities in cats with chronic diarrhoea consistently show reduced diversity, depletion of beneficial short-chain fatty acid producers such as Faecalibacterium, and overgrowth of Escherichia coli, Clostridium perfringens, and certain Bacteroides species. These changes are not simply downstream of diarrhoea; they actively prolong inflammation through toxin production, mucin degradation, and altered immune signalling.

The dysbiotic profile typically features lower butyrate production alongside expansion of facultative anaerobes. In humid coastal regions such as Victoria's Mornington Peninsula and parts of tropical north Queensland, where faecal organisms persist longer in the environment, breaking this cycle is harder. Faecal microbiota transplantation and targeted nutritional support are therefore gaining traction among Australian internists seeking to restore balance.

How co-infection changes the intestinal environment

When protozoa and dysbiotic bacteria coexist, the inflammatory milieu alters epithelial tight junctions and mucosal immune tone. Tritrichomonas foetus disrupts barrier integrity and skews responses toward Th1 activity, while coliform overgrowth intensifies innate immune activation through lipopolysaccharide signalling. Biopsy frequently reveals villous atrophy and crypt hyperplasia reflecting this combined assault.

This shared inflammatory backdrop creates a permissive niche for further disturbance. Affected cats often show progressive weight loss, reduced appetite, and dull coat quality, mirroring the chronic enteropathy picture in dogs. A holistic lens that integrates lifestyle, diet, and pathogen load generally outperforms single-pathogen thinking.

Lifestyle and environmental risk factors

Indoor cats fed exclusively commercial diets in cities like Adelaide or Perth still develop protozoal-bacterial co-infections, often linked to contaminated water, multi-pet households, or recent shelter adoption. Outdoor and semi-feral cats in rural New South Wales and Western Australia face a different set of risks, including access to stagnant water sources that harbour both Giardia cysts and opportunistic coliforms.

Stress also shapes microbial composition. Relocation, construction noise, or the introduction of a new dog can trigger subclinical dysbiosis that primes the gut for protozoal colonisation. Australian clinicians who ask about household change during history-taking often uncover pivotal context that simple stool testing misses.

Diagnostic approach in Australian practice

The standard workup begins with faecal flotation, wet-mount microscopy for motile trophozoites, and PCR panels for Tritrichomonas, Giardia, and Cryptosporidium. In regional South Australia and parts of Tasmania, where courier turnaround to commercial laboratories may stretch to several days, in-house antigen kits offer a practical first screen. Faecal scoring charts and detailed chronicity timelines help separate protozoal-driven disease from primary inflammatory bowel disease.

Diagnostic imaging and intestinal biopsy, reserved for refractory cases, commonly show combined lesions consistent with both infectious and inflammatory activity. Networks supported by the Australian Veterinary Association, alongside teaching hospitals at the University of Melbourne and the University of Sydney, offer GPs a reliable second-opinion pathway. Building these referral relationships is often as valuable as any single diagnostic test when distinguishing treatable co-infection from entrenched enteropathy.

Management strategies for dual involvement

Effective treatment attacks protozoa while restoring microbial balance. Ronidazole remains the mainstay for Tritrichomonas foetus, with clear owner education on safe handling essential in any clinic protocol. For Giardia, metronidazole or fenbendazole courses are common, but environmental decontamination of litter trays, bedding, and shared bowls is non-negotiable, otherwise reinfection rapidly undoes pharmacologic gains.

Nutritional intervention forms the second pillar. Highly digestible, fibre-modified diets reduce fermentative load and support colonocyte recovery. Many Australian clinics pair these diets with multi-strain probiotics and track faecal scores over four to eight weeks. Relapse cases often prompt reconsideration of bacterial dysbiosis, since clearing protozoa does not automatically reset microbial communities, particularly in cats with a long chronicity.

Continuing education and clinical resources

Co-infection by protozoa and bacteria is now recognised as one pathway into feline chronic enteropathy rather than a separate entity. Recognising this overlap changes how clinicians interpret laboratory results and counsel owners around realistic recovery timelines. For practitioners seeking formal acknowledgement of their continued learning in this field, a certificate of participation is available through the Hill's ActivBiome platform alongside on-demand webinars and downloadable resources.

Feature	Protozoal-driven patterns	Bacterial dysbiosis patterns
Common agents	Tritrichomonas foetus, Giardia, Cystoisospora	E. coli, C. perfringens, Bacteroides expansion
Typical age	Younger cats, multi-cat environments	Any age, often after antibiotic exposure
Stool character	Foul, mucus-rich, intermittent	Soft, variable, sometimes bloody
Diagnostic tools	PCR, wet-mount, antigen kits	qPCR dysbiosis panels, culture
Treatment focus	Antiparasitics, environmental hygiene	Microbiome restoration, diet, targeted probiotics
Prognosis	Good with clearance and hygiene	Variable, depends on barrier recovery